Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401005
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-04-30
Brief Title:
SBRT Chemotherapy and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer TNBC
Sponsor:
Hubei Cancer Hospital
Organization:
Hubei Cancer Hospital
Organization Data
Organization:
Hubei Cancer Hospital
Class:
OTHER
Study ID:
HBCH-RT-2024-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hubei Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
HAN GUANG
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hubei Cancer Hospital
Old Name:
None
Old Organization:
None